Evaluation of efficacy of intradermal injection therapy vs derma roller application for administration of QR678 Neo(R) hair regrowth formulation for the treatment of Androgenetic Alopecia-A prospective study

被引:9
|
作者
Shome, Debraj [1 ,2 ]
Kapoor, Rinky [3 ]
Vadera, Sapna [1 ]
Doshi, Komal [1 ]
Patel, Ghanshyam [4 ]
Mohammad Khan, Temoor [5 ]
机构
[1] Esthet Clin, Dept Facial Plast Surg & Facial Cosmet Surg, Mumbai, Maharashtra, India
[2] Esthet Clin, Mumbai, Maharashtra, India
[3] Esthet Clin, Dept Dermatol Cosmet Dermatol Dermatosurg, Mumbai, Maharashtra, India
[4] Veeda Clin Res, Ahmadabad, Gujarat, India
[5] Osmania Med Coll & Hosp, Dept Plast Surg, Hyderabad, India
关键词
androgenetic alopecia; derma roller; hair regrowth therapy; intradermal application; QR678; Neo; PAPILLA CELLS;
D O I
10.1111/jocd.14139
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Non-surgical hair restoration is one of the most exciting and innovative fields in cosmetic surgery today. The addition of latest technique like derma roller seeks to achieve better results for delivering pharmaceutical solution for hair growth in comparison with topical administration. Aim We aim to compare intradermal injection vs. derma roller technique for administration of QR678Neo(R)hair regrowth therapy for the treatment of androgenetic alopecia (AGA) in male and female patients. Method A sum of 50 patients in the age range of 20-70 years with AGA were included and divided into 2 groups; Group A (intradermal) and Group B (derma roller). Intradermal injection of QR678Neo(R) formulation and derma roller with superficial application of QR678Neo(R) was given in each group. Assessment was done using hair pull test, global photographic assessment, video-microscopic assessment, and patient subjective assessment at baseline, 6 months, and 1 year. Results Significant diminution in hair fall was seen in both the groups. All the video-microscopic assessment factors were better in intradermal injection group compared to the derma roller group, but not significant. Erythema and pain were high in derma roller group in compare to intradermal. Conclusion Derma roller technique is more convenient and easy to perform, especially when the availability of a trained person to carry out intradermal injection is not feasible, it gives satisfactory results. It is also beneficial in needle phobic and apprehensive patients. Though the results are more efficacious with intradermal scalp injection technique, this study established satisfactory results with derma roller technique as well.
引用
收藏
页码:3299 / 3307
页数:9
相关论文
共 7 条
  • [1] Evaluation of efficacy of derma roller sizes vs topical application for administration of QR678 Neo® hair regrowth formulation in the treatment of androgenetic alopecia
    Shome, Debraj
    Tandel, Harshal
    Kumar, Vaibhav
    Kapoor, Rinky
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) : 6528 - 6530
  • [2] Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS-A prospective study
    Kapoor, Rinky
    Shome, Debraj
    Doshi, Komal
    Patel, Ghanshyam
    Vadera, Sapna
    JOURNAL OF COSMETIC DERMATOLOGY, 2020, 19 (10) : 2637 - 2646
  • [3] Evaluation of efficacy of QR678(R)and QR678(R)Neo hair growth factor formulation in the treatment of persistent chemotherapy-induced alopecia caused due to cytotoxic chemotherapy-A prospective pilot study
    Kapoor, Rinky
    Shome, Debraj
    Doshi, Komal
    Vadera, Sapna
    Patel, Ghanshyam
    Kumar, Vaibhav
    JOURNAL OF COSMETIC DERMATOLOGY, 2020, 19 (12) : 3270 - 3279
  • [4] Effectiveness of QR678 and QR678 Neo(R) with intralesional corticosteroid vs. intralesional corticosteroid alone in the treatment of alopecia areata -A randomized, comparative, prospective study
    Shome, Debraj
    Kapoor, Rinky
    Doshi, Komal
    Patel, Ghanshyam
    Vadera, Sapna
    Kumar, Vaibhav
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (01) : 358 - 367
  • [5] Comparison of QR 678(R) & QR678(R) Neo as monotherapy and as combination therapy with 5% Minoxidil solution and oral Finasteride in the treatment of male androgenetic alopecia-Which is better?
    Shome, Debraj
    Kapoor, Rinky
    Doshi, Komal
    Patel, Ghanshyam
    Vadera, Sapna
    Kumar, Vaibhav
    JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (06) : 1763 - 1765
  • [6] Efficacy of QR678 Neo® hair growth factor formulation for the treatment of hair loss in Covid-19-induced persistent Telogen Effluvium-A prospective, clinical, single-blind study
    Shome, Debraj
    Kapoor, Rinky
    Surana, Monika
    Vadera, Sapna
    Shah, Ronak
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (01) : 16 - 23
  • [7] Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo® hair growth factor formulation: A phase-IV, open-label, single-arm multi-ethnicity clinical trial
    Clinic, Aayna
    Asper, Annette
    Mittal, Apoorva
    Shome, Debraj
    Parbhoo, Deepa
    Thanzama, James
    Doshi, Komal
    Sachde, Neha
    Gaunkar, Ridhima
    Kapoor, Rinky
    Thakkar, Rukshmani
    Sion, Simal
    Shetty, Sushant
    Kumar, Vaibhav
    Parveen, Veena
    Singhal, Vivek
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (02) : 580 - 589